Deng Yu, Li Yujiang, Wu Tiantong, Chen Xuyuan, Li Xiang, Cai Kaican, Wu Xu
Department of Thoracic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China.
Department of Thoracic and Cardiovascular Surgery, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Biol Proced Online. 2022 Mar 23;24(1):4. doi: 10.1186/s12575-022-00165-z.
Objective Esophageal carcinoma (ESCA) is deadly cancer worldwide with unknown etiology. This study aimed to investigate the impact and mechanism of RAD6 on the development of Esophageal squamous cell carcinoma (ESCC).Expressions of RAD6A and RAD6B in ESCA were investigated from TCGA dataset and their expressions in tissue sample of ESCA patients and cells were determined. Functional experiments were conducted to explore the impact of RAD6A and RAD6B on malignant characteristics of several kinds of ESCC cells. Animal experiment was established and injected with RAD6A and RAD6B shRNA to evaluate the effect on tumor growth.RAD6A and RAD6B were up-regulated in ESCC cells and tissues. Overexpressed RAD6A and RAD6B similarly increased ESCC cell proliferation, invasion and migration and silencing of RAD6 exerted opposite effects. Knockdown of RAD6A suppressed tumor growth and decreased the level of H2B, as data demonstrated positive correlation between RAD6A and CCNB1 in ESCC tissues.Collectively, this study elucidates that RAD6 is up-regulated in ESCC and promotes the progression of ESCC through up-regulation of CCNB1 to enhance H2B ubiquitination. These evidence provide a novel insight into the pathogenesis of ESCC and might contribute to the development of targeted therapy.
目的 食管癌(ESCA)是全球范围内的致命癌症,病因不明。本研究旨在探讨RAD6对食管鳞状细胞癌(ESCC)发生发展的影响及其机制。从TCGA数据集中研究RAD6A和RAD6B在ESCA中的表达,并测定它们在ESCA患者组织样本和细胞中的表达。进行功能实验以探究RAD6A和RAD6B对几种ESCC细胞恶性特征的影响。建立动物实验并注射RAD6A和RAD6B的shRNA以评估对肿瘤生长的影响。RAD6A和RAD6B在ESCC细胞和组织中上调。过表达的RAD6A和RAD6B同样增加了ESCC细胞的增殖、侵袭和迁移,而沉默RAD6则产生相反的效果。敲低RAD6A抑制肿瘤生长并降低H2B水平,数据表明ESCC组织中RAD6A与CCNB1呈正相关。总体而言,本研究阐明RAD6在ESCC中上调,并通过上调CCNB1增强H2B泛素化促进ESCC进展。这些证据为ESCC的发病机制提供了新的见解,并可能有助于靶向治疗的发展。